Barney CC, Krach LE, Rivard PF, Belew JL, Symons FJ Motor function predicts parent-reported musculoskeletal pain in children with cerebral palsy. Pain Res Manag. 2013 Nov-Dec;18(6):323-7. doi: 10.1155/2013/813867.
Barney CC, Merbler AM, Simone DA, Walk D, Symons FJ Investigating the Feasibility of a Modified Quantitative Sensory Testing Approach to Profile Sensory Function and Predict Pain Outcomes Following Intrathecal Baclofen Implant Surgery in Cerebral Palsy. Pain Med. 2020 Jan 1;21(1):109-117. doi: 10.1093/pm/pnz114.
Barney CC, Stibb SM, Merbler AM, Summers RLS, Deshpande S, Krach LE, Symons FJ Psychometric properties of the brief pain inventory modified for proxy report of pain interference in children with cerebral palsy with and without cognitive impairment. Pain Rep. 2018 Jul 17;3(4):e666. doi: 10.1097/PR9.0000000000000666. eCollection 2018 Jul-Aug.
Barney CC, Tervo R, Wilcox GL, Symons FJ A Case-Controlled Investigation of Tactile Reactivity in Young Children With and Without Global Developmental Delay. Am J Intellect Dev Disabil. 2017 Sep;122(5):409-421. doi: 10.1352/1944-7558-122.5.409.
Breau LM, Camfield CS, McGrath PJ, Finley GA The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med. 2003 Dec;157(12):1219-26. doi: 10.1001/archpedi.157.12.1219.
Breau LM, MacLaren J, McGrath PJ, Camfield CS, Finley GA Caregivers' beliefs regarding pain in children with cognitive impairment: relation between pain sensation and reaction increases with severity of impairment. Clin J Pain. 2003 Nov-Dec;19(6):335-44. doi: 10.1097/00002508-200311000-00001.
Bursch B, Tsao JC, Meldrum M, Zeltzer LK Preliminary validation of a self-efficacy scale for child functioning despite chronic pain (child and parent versions). Pain. 2006 Nov;125(1-2):35-42. doi: 10.1016/j.pain.2006.04.026. Epub 2006 Jun 5.
Delafontaine A, Presedo A, Mohamed D, Lopes D, Wood C, Alberti C Equimolar mixture of nitroux oxyde and oxygen during post-operative physiotherapy in patients with cerebral palsy: A randomized, double-blind, placebo-controlled study. Eur J Pain. 2017 Nov;21(10):1657-1667. doi: 10.1002/ejp.1071. Epub 2017 Jul 20.
Duckworth AL, Quinn PD Development and validation of the short grit scale (grit-s). J Pers Assess. 2009 Mar;91(2):166-74. doi: 10.1080/00223890802634290.
Engel JM, Wilson S, Tran ST, Jensen MP, Ciol MA Pain catastrophizing in youths with physical disabilities and chronic pain. J Pediatr Psychol. 2013 Mar;38(2):192-201. doi: 10.1093/jpepsy/jss103. Epub 2012 Oct 1.
Gan TJ Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017 Sep 25;10:2287-2298. doi: 10.2147/JPR.S144066. eCollection 2017.
Geil D, Thomas C, Zimmer A, Meissner W Chronified Pain Following Operative Procedures. Dtsch Arztebl Int. 2019 Apr 12;116(15):261-266. doi: 10.3238/arztebl.2019.0261.
Goubert L, Eccleston C, Vervoort T, Jordan A, Crombez G Parental catastrophizing about their child's pain. The parent version of the Pain Catastrophizing Scale (PCS-P): a preliminary validation. Pain. 2006 Aug;123(3):254-263. doi: 10.1016/j.pain.2006.02.035. Epub 2006 Apr 27.
Harrison, P L., Oakland, T., Adaptive Behavior Assessment System, Third Edition [Manual]. 2015, Torrance, CA: Western Psychological Services.
Hermann C, Hohmeister J, Zohsel K, Ebinger F, Flor H The assessment of pain coping and pain-related cognitions in children and adolescents: current methods and further development. J Pain. 2007 Oct;8(10):802-13. doi: 10.1016/j.jpain.2007.05.010. Epub 2007 Jul 12.
Matson JL, Malone CJ Validity of the sleep subscale of the Diagnostic Assessment for the Severely Handicapped-II (DASH-II). Res Dev Disabil. 2006 Jan-Feb;27(1):85-92. doi: 10.1016/j.ridd.2005.03.001. Epub 2005 May 31.
Munger ME, Aldahondo N, Krach LE, Novacheck TF, Schwartz MH Long-term outcomes after selective dorsal rhizotomy: a retrospective matched cohort study. Dev Med Child Neurol. 2017 Nov;59(11):1196-1203. doi: 10.1111/dmcn.13500. Epub 2017 Aug 8.
Rivard PF, Nugent AC, Symons FJ Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy. Clin J Pain. 2009 Jun;25(5):413-7. doi: 10.1097/AJP.0b013e31819a6d07.
Savedra MC, Holzemer WL, Tesler MD, Wilkie DJ Assessment of postoperation pain in children and adolescents using the adolescent pediatric pain tool. Nurs Res. 1993 Jan-Feb;42(1):5-9.
Tucker A, McCusker D, Gupta N, Bunn J, Murnaghan M Orthopaedic Enhanced Recovery Programme for Elective Hip and Knee Arthroplasty - Could a Regional Programme be Beneficial? Ulster Med J. 2016 May;85(2):86-91.
Tyler EJ, Jensen MP, Engel JM, Schwartz L The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil. 2002 Feb;83(2):236-9. doi: 10.1053/apmr.2002.27466.
Wilson NC, Chong J, Mackey AH, Stott NS Reported outcomes of lower limb orthopaedic surgery in children and adolescents with cerebral palsy: a mapping review. Dev Med Child Neurol. 2014 Sep;56(9):808-14. doi: 10.1111/dmcn.12431. Epub 2014 Mar 28.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.